| Mr Paul Matthew Crum, CRNA | |
|
4305 New Shepherdsville Rd, Bardstown, KY 40004 | |
| (502) 350-5032 | |
| (502) 350-5022 |
| Full Name | Mr Paul Matthew Crum |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 16 Years |
| Location | 4305 New Shepherdsville Rd, Bardstown, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1376798918 | NPI | - | NPPES |
| 7100232210-KOHMG | Medicaid | KY | |
| P01977534-KOHMG | Other | KY | RR MEDICARE |
| 300011007A-KOHMG | Medicaid | IN | |
| K074154-KOHMG | Other | KY | KY MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | RN 274000 (Ohio) | Secondary |
| 367500000X | Nurse Anesthetist, Certified Registered | 3007686 (Kentucky) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Spring View Hospital | Lebanon, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kentucky Anesthesia Group Psc | 4082527890 | 37 |
News Archive
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
A new report describes cancer among Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs), and reports striking variation in the cancer burden within this population, reflecting vast differences in exposure to cancer risk factors.
Several graduate and Ph.D. students at Louisiana Tech University, and Dr. David Mills, professor of biological sciences and faculty in Tech's Center for Biomedical Engineering and Rehabilitation Science, are participating in poster and platform presentations at the 2012 Experimental Biology meeting, this week in San Diego, California.
› Verified 7 days ago
| Entity Name | Commonwealth Anesthesia, Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437196300 PECOS PAC ID: 5092627521 Enrollment ID: O20031104000115 |
News Archive
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
A new report describes cancer among Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs), and reports striking variation in the cancer burden within this population, reflecting vast differences in exposure to cancer risk factors.
Several graduate and Ph.D. students at Louisiana Tech University, and Dr. David Mills, professor of biological sciences and faculty in Tech's Center for Biomedical Engineering and Rehabilitation Science, are participating in poster and platform presentations at the 2012 Experimental Biology meeting, this week in San Diego, California.
› Verified 7 days ago
| Entity Name | Kentucky Anesthesia Group Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073608634 PECOS PAC ID: 4082527890 Enrollment ID: O20031107000511 |
News Archive
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
A new report describes cancer among Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs), and reports striking variation in the cancer burden within this population, reflecting vast differences in exposure to cancer risk factors.
Several graduate and Ph.D. students at Louisiana Tech University, and Dr. David Mills, professor of biological sciences and faculty in Tech's Center for Biomedical Engineering and Rehabilitation Science, are participating in poster and platform presentations at the 2012 Experimental Biology meeting, this week in San Diego, California.
› Verified 7 days ago
| Entity Name | Lec Ancillary Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982917365 PECOS PAC ID: 0345364725 Enrollment ID: O20100908000467 |
News Archive
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
A new report describes cancer among Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs), and reports striking variation in the cancer burden within this population, reflecting vast differences in exposure to cancer risk factors.
Several graduate and Ph.D. students at Louisiana Tech University, and Dr. David Mills, professor of biological sciences and faculty in Tech's Center for Biomedical Engineering and Rehabilitation Science, are participating in poster and platform presentations at the 2012 Experimental Biology meeting, this week in San Diego, California.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Paul Matthew Crum, CRNA Po Box 936, London, KY 40743-0936 Ph: (606) 330-7818 | Mr Paul Matthew Crum, CRNA 4305 New Shepherdsville Rd, Bardstown, KY 40004 Ph: (502) 350-5032 |
News Archive
The cancer drug bevacizumab (Avastin®) offers only a modest benefit in prolonging disease progression in patients with advanced stage breast cancer, according to a systematic review by Cochrane researchers. The researchers assessed the efficacy of bevacizumab in combination with chemotherapy, an established cancer treatment in this indication, and found no overall survival benefit when adding bevacizumab to chemotherapy.
A new study shows that some anti-inflammatory medicines, such as aspirin, estrogen, and Fluimucil, can improve the efficacy of existing schizophrenia treatments. This work is being presented at the European College of Neuropsychopharmacology conference in Berlin.
A new report describes cancer among Asian Americans, Native Hawaiians, and Pacific Islanders (AANHPIs), and reports striking variation in the cancer burden within this population, reflecting vast differences in exposure to cancer risk factors.
Several graduate and Ph.D. students at Louisiana Tech University, and Dr. David Mills, professor of biological sciences and faculty in Tech's Center for Biomedical Engineering and Rehabilitation Science, are participating in poster and platform presentations at the 2012 Experimental Biology meeting, this week in San Diego, California.
› Verified 7 days ago
Price Richardson, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5022 | |
Mary Martha Dowell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
Scott Kendall Ohler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Anesthesia Department, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
Roger K Colbert, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5000 | |
Alan Todd Dossett, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 4305 New Shepherdsville Rd, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
David S Ellison, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 4305 New Shepherdsville Rd, Anesthesia Department, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 | |
David Wayne Kendrick, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 4305 New Shepherdsville Rd, Anesthesia Department, Bardstown, KY 40004 Phone: 502-350-5032 Fax: 502-350-5022 |